http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2273488-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 |
| filingDate | 2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_958d5be0d3c7de78a64657d341b1c143 |
| publicationDate | 2006-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2273488-C1 |
| titleOfInvention | Multifunctional therapeutic and preventive biological composite and method for producing it |
| abstract | FIELD: medicine. n SUBSTANCE: composite remedy comprises enzymatic lactoserum hydrolyzate and additional hydrocarbon hydrolyzate giving dry substance concentration equal to 40-50% in end product. Ready biological composite is known to be polycomponent hydrolyzate mixture produced by combined enzymatic hydrolysis of lactate and hydrocarbon ingredients. The hydrocarbon ingredient is introduced until dry substance content is equal to 12-18% in total hydrolyzate amount at the moment of practically complete hydrolysis of lactate ingredient, additionally incubated at t=28-46°C with following mixture product being condensed to reach 40-50% of dry substance content. Substance selected from group composed of sugar adobe, dextran, molasses, cellular tissue or starch hydrolyzate. One more object is method for producing biological composite. The method involves hydrolyzing lactoserum or its derivative with lactobacilli at t=28-46°C with continuous fractional NaOH neutralization. Hydrocarbon is introduced into reaction mixture at the moment of practically complete hydrolysis of lactate ingredient to bring dry substance content to 12-18%. Additional incubation is carried out during 5-7 h under the same conditions as the initial ones. n EFFECT: wide biological activity spectrum; increased organism immunity status. n 6 cl, 6 tbl |
| priorityDate | 2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.